Nasdaq Notifies Titan Medical Regarding Audit Committee Requirements
Titan Medical Inc. (the “Company” or “Titan”) (NASDAQ:TMDI, TSX:TMD) today announced senior leadership changes and the receipt of a notification from the Nasdaq Stock Market LLC Listing Qualifications Department stating that following the resignation of Heather Knight from the Company’s board of directors and audit committee, the Company no longer complies with Nasdaq’s audit committee requirement set forth in Nasdaq Rule 5605.